Aim. Odontogenic myxoma is a benign intraosseous neoplasm of the jaws, with a locally aggressive behavior and a high recurrence rate. CD-105 is a homodimeric cell membrane glycoprotein and is a component of the TGF-β1 growth factor receptor complex that modulates angiogenesis by regulating the proliferation, differentiation and cellular migration. The aim of this study is to quantify the microvascular density of the odontogenic myxoma based on the expression of CD-105. Materials and Methods. The analysis included 18 odontogenic myxoma and 18 dental follicles as controls. A standard immunohistochemical procedure was performed with the CD-105 antibody. Five representative fields (40×) of the odontogenic myxoma and the dental follicles were selected to determine the microvascular density, which was then followed by a descriptive and comparative statistical analysis. Results. Dental follicles presented a significantly higher microvascular density compared with odontogenic myxoma (P = .001). The odontogenic myxoma smaller than 3 cm showed a greater microvascular density than those larger than 3 cm in size (P > .05), and the microvascular density was lower in large odontogenic myxomas as compared with the dental follicles (P = .003). Conclusion. A weaker expression of CD-105 in odontogenic myxoma might indicate a lower angiogenic activity, suggesting that vascular proliferation has a limited role in the growth mechanisms and in the aggressive behavior of this neoplasm.
Introduction
Odontogenic myxoma (OM) is a benign intraosseous neoplasm of the jaws with a locally aggressive behavior and a high recurrence rate. [1] [2] [3] Its frequency ranges from 2.2% to 17.7% of all odontogenic tumors. [4] [5] [6] [7] This tumor develops within a wide age range, with a greater incidence during the second and third decades, and has a 2 to 1 predilection for females. Two-thirds of the cases are located in the mandible, developing as a slow, progressive and generally asymptomatic tumoral growth. [1] [2] [3] 5 It has a marked potential to infiltrate and destroy bone, and a high recurrence rate. [8] [9] [10] Among the possible mechanisms of growth of OM, the increase in cellular proliferation, [11] [12] [13] the decrease in apoptosis, [11] [12] [13] the production of extracellular matrix degrading enzymes, 11, 14, 15 the accumulation of orosomucoid-1 in the extracellular matrix, 16, 17 the induction to bone reabsorption, 18 and the increase in angiogenesis and production of the vascular endothelial growth factor-A (VEGF-A) 17 have been considered. CD-105 is a homodimeric cell membrane glycoprotein, component of the growth factor β1 (TGF-β1) receptorcomplex that modulates angiogenesis by regulating the proliferation, differentiation and endothelial cell migration. [19] [20] [21] The expression of CD-105 is a characteristic property of the newly formed blood vessels as there is a lack of its expression in previously-existing blood and lymphatic vessels. 19, 20, 22 The quantification of the expression of this protein has been proposed to evaluate neoangiogenesis in different types of tumors. 21, 23 On the other hand, microvascular density (MVD) is a useful histomorphological parameter to evaluate tumor angiogenesis, which is considered an indicator of tumor growth, and has been correlated with the aggressive behavior of tumors. 17, 20, 22 The aim of this study was to compare the MVD in OM and dental follicle (DF) based on the expression of CD-105, in an effort to obtain new information that may contribute to understand the possible pathogenic mechanisms implicated in the growth of this neoplasm.
Materials and Methods
Tissue samples from inflammation-free areas of 18 OM (10 female and 8 male; with a mean age of 32.83 years; range 10-53 years) and of 18 DF free of inflammation (9 female and 9 male; with a mean age of 14.4 years; range 9-22 years) diagnosed in the Oral Pathology Laboratory of the Universidad Autónoma Metropolitana Xochimilco and in a private service of oral pathology diagnosis in Mexico City.
This study was approved by the Research Committee of the Biological and Health Sciences Division of the Universidad Autonóma Metropolitana Xochimilco.
Relevant information on the size of the OMs included in this study was obtained from the clinical files. The histopathological diagnosis of each case was confirmed on hematoxylin and eosin-stained sections and was based on the microscopic criteria included in the current World Health Organization histological classification of tumors. 24 The OMs were classified according to their size at diagnosis as small odontogenic myxomas (SOM), when tumors were up to 3 cm (n = 4), and as large odontogenic myxomas (LOM) when they were larger than 3 cm (n = 14).
Two micrometer-thick sections from each paraffin block were deparaffinized, rehydrated and treated with 0.1 mol/L sodium citrate (pH 6.2) to expose the antigenic epitopes. The endogenous peroxidases were blocked with 0.9% hydrogen peroxide. The primary antibody was incubated in a humidifying chamber (Sequenza Slide Rack) with a 1:50 dilution of the anti-CD-105 polyclonal antibody (BioSB, Santa Barbara, CA, USA) and with the S2022 diluent (DAKO, Carpinteria, CA, USA) for 45 minutes. The reaction was visualized with the Mouse/Rabbit Immunodetector System (BioSB, Santa Barbara, CA, USA) and revealed with the 3,3-diaminobenzidine hydrochloride (DAB) substrate showing as a brown-colored precipitate. The samples were counterstained with Gill's hematoxylin and mounted with a permanent medium (Eukitt).
Three oral pathologists assessed the immunohistochemical expression individually before reaching a consensus. The assessment criteria were based on previous studies. [18] [19] [20] 23, 25, 26 The standardization of the examiners showed a kappa index of 0.88.
The MVD was analyzed using the method proposed by Vered et al 27 and with the grid suggested by Bologna-Molina et al. 28 Five microphotographs of the most representative areas at 40× were taken with a digital camera (Olympus CX 31; Olympus, San Diego, CA, USA). Subsequently, a 6 × 6 grid was placed over the photograph to quantify the vessels located in the intersection areas (Figure 1) . In cases where the wall or the lumen of the vessel intercepted more than one point, only one was taken into consideration. In each picture, cell counting started in the top left frame of the grid and finished in the top right frame (Figure 1 ). The number of positive vessels was counted manually in each image. The average of counts in these fields was considered in the analysis. This procedure was followed to obtain the MVD from the OMs and the DFs.
With all the data obtained, a descriptive and comparative analysis was performed using the SPSS version 15.0 software (SPSS Inc, IBM, Armonk, NY). The means of the MVD were compared with the Mann-Whitney U statistical Table 1 shows the relevant data of the MVD found in the OM and DF studied cases. There was a significantly higher MVD in DFs as compared with OMs (P = .001). The expression of CD-105 in OMs and DFs is presented in Figure 2 , showing the lack of expression of the marker in mature vessels. Although SOM showed a greater MVD (0.4) than LOM (0.28), this difference was nonsignificant (P = .521). On the other hand, the MVD was lower in LOM as compared with the DFs (P = .003).
Results

Discussion
Tumor growth requires blood supply to provide oxygen, metabolites and growth factors needed for cell proliferation. Angiogenesis is the process of formation and development of new blood vessels from previously existing vessels; in pathological conditions, this process contributes to tumor growth and favors the development of metastasis.
Various studies 18, 20, 25, 26 have employed the expression of CD-105 to assess tumor angiogenesis and the MVD in odontogenic tumors, and have demonstrated a greater specificity of CD-105 with respect to other endothelial markers for identification of neoangiogenesis. To our knowledge, this is the first study evaluating tumor angiogenesis in OMs with CD-105.
The increase in MVD is considered an indicator of tumor growth and a positive predictor of metastasis, and is consequently associated with survival and aggressiveness of some neoplasms. 20, 22 Furthermore, it may be used to study the antineoplastic effect of potential angiogenic therapy, even in cases of recurrent or highly aggressive odontogenic tumors. 25 We consider that the currently available methodology used to quantify angiogenesis through MVD should be standardized with an appropriate and reproducible method in order to be useful for comparing data among different studies. 18, 25, 26 Our work followed the method described by Vered et al, 27 as it is the most simple and user-friendly. We complemented it with the grid described by our group, 28 which, to our understanding, complies with the necessary criteria for objectivity and reproducibility.
We observed in our study that although the OMs and the DFs pose similar histomorphological features, the tumors presented a significantly lower MVD. These results would support previous observations from our group 17 on the minor role played by angiogenesis in the growth and aggressiveness of this neoplasm, as opposed to what seems to occur with the expression of CD-105 in other odontogenic lesions. 18, 26 In this regard, when comparing the MVD between SOM and LOM, a lower yet nonsignificant MVD was observed in the larger neoplasms, which could be associated with different stages of tumoral growth.
Cell proliferation seem to be low in OM, [11] [12] [13] and thus it has been suggested that the growth of this tumor is based on its water-binding capacity that helps increase the hydrostatic pressure and induce the generation of mechanisms of bone reabsorption. 11, 13, 29 Furthermore, a very recent study from our group 17 demonstrated that the orosomucoid-1 protein is present in OM and this fact suggest its overexpression might be a contributing factor for the classical viscous and mucoid structural configuration of OM, which, at least partially, is responsible for its invasive nature into the trabecular bone. Furthermore, a correlation between the expression of orosomucoid-1 and VEGF is described, suggesting the participation of both proteins in the mechanism of angiogenesis in this benign neoplasm. 17 In conclusion, our results suggest that neoangiogenesis plays a minor role in the growth of the OMs and supports the existence of other mechanisms of expansion and progression of this neoplasm.
